Bacteriostatic Sodium Chloride Injection, Solution
NDC 0409-1966
Product Information
Bacteriostatic Sodium Chloride (sodium chloride) is a NDA-approved product labeled by Hospira, Inc.. This product is used to treat dryness inside the nose (nasal passages). It is supplied as a injection, solution for intramuscular; intravenous; subcutaneous administration. This product entry covers the primary NDC 0409-1966 and 3 associated package configurations. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Clinical Specifications
- Intramuscular - Administration within a muscle.
- Intravenous - Administration within or into a vein or veins.
- Subcutaneous - Administration beneath the skin; hypodermic. Synonymous with the term SUBDERMAL.
Labeler & Regulatory Data
Marketing Timeline
Code Structure Chart
Product Details
What is NDC 0409-1966?
What are the uses of this product?
What are Active Ingredients of this product?
- SODIUM CHLORIDE 9 mg/mL - A ubiquitous sodium salt that is commonly used to season food.
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- SODIUM CHLORIDE (UNII: 451W47IQ8X)
- CHLORIDE ION (UNII: Q32ZN48698) (Active Moiety)
- SODIUM CATION (UNII: LYR4M0NH37) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- BENZYL ALCOHOL (UNII: LKG8494WBH)
- HYDROCHLORIC ACID (UNII: QTT17582CB)
- WATER (UNII: 059QF0KO0R)
What is the NDC to RxNorm Crosswalk for this product?
- RxCUI: 313002 - sodium chloride 0.9 % Injectable Solution
- RxCUI: 313002 - sodium chloride 9 MG/ML Injectable Solution
- RxCUI: 313002 - NaCl 9 MG/ML Injectable Solution
* Please review the full disclaimer at the bottom of this page.